Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

April 16 2024 - J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales

J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?
Humira biosimilar scripts take off
Intra-Cellular launches 26% to record high, breaking out after depression drug scores big
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo’s Product Pipeline Needs Priming

WSJ Online

Tuesday, July 26, 2011 - 1:40pm

tags:

GSK, pipelines, patents

Earnings Preview: Mylan Inc.

Yahoo/Zacks.com

Tuesday, July 26, 2011 - 11:10am

tags:

earnings, Mylan

Watson Pharmaceuticals 2Q profit dips 25 percent

Yahoo/AP

Tuesday, July 26, 2011 - 10:44am

tags:

Watson Pharmaceuticals, earnings

GlaxoSmithKline cost-cutting drives $1.8 billion profit in second quarter; Japan sales strong

Yahoo/AP

Tuesday, July 26, 2011 - 10:42am

tags:

Specialty Drugs Entice BTG While Awaiting Varicose-Vein Medicine

Bloomberg

Tuesday, July 26, 2011 - 10:40am

tags:

varicose vein, BTG

Conflict-of-Interest Rules May Be Relaxed in 2012, Hamburg Says

Bloomberg

Monday, July 25, 2011 - 7:40pm

tags:

FDA, conflict-of-interest, Peggy Hamburg, physician payments

Pharmasset research costs climb in 3Q loss

Yahoo/AP

Monday, July 25, 2011 - 7:38pm

tags:

Pharmasset, earnings

Bristol-Myers' Acquisition Could Pay for Itself

Motley Fool

Monday, July 25, 2011 - 7:37pm

tags:

M&A, Bristol-Myers Squibb, Amira

GSK sues Watson Pharma; buys back 1.6 million shares

Bizjournals.com

Monday, July 25, 2011 - 7:35pm

tags:

stock buyback, GSK, Watson Pharmaceuticals, lawsuits, Jalyn, benign prostatic hyperplasia

Whistleblower Lawsuit Against Amgen Is Reinstated

Pharmalot

Monday, July 25, 2011 - 1:38pm

tags:

Amgen, whistleblower lawsuits, kickbacks, False Claims Act, Medicaid, Medicare

Watson Pharmaceuticals Earnings Preview

Benzinga

Monday, July 25, 2011 - 1:36pm

tags:

Watson Pharmaceuticals, earnings

EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s

Xconomy

Monday, July 25, 2011 - 1:32pm

tags:

EnVivo, Fidelity Biosciences, Alzheimer's disease, EVP-0962

Drug prices to plummet in wave of expiring patents

Yahoo/AP

Monday, July 25, 2011 - 1:29pm

tags:

drug prices, patents, generics

Human Genome Incurs Wider Loss

Yahoo/Zacks.com

Monday, July 25, 2011 - 1:27pm

tags:

Human Genome Sciences, earnings

Will pharma fight the Express-Medco deal?

Fierce Pharma

Monday, July 25, 2011 - 12:02pm

tags:

Express Scripts, Medco, M&A, PBMs

Bristol-Myers Squibb Co. Second Quarter Earnings Sneak Peek

Yahoo/Wall St. Cheat Sheet

Monday, July 25, 2011 - 11:53am

tags:

earnings, Bristol-Myers Squibb

4-Star Stocks Poised to Pop: Amarin

Motley Fool

Monday, July 25, 2011 - 10:51am

tags:

Biogen wins conditional EU approval for MS drug

Bizjournals.com

Monday, July 25, 2011 - 10:25am

tags:

Biogen Idec, Europe, MS, multiple sclerosis, Fampyra

Broker offers protection to pharma groups

FT.com

Monday, July 25, 2011 - 10:24am

tags:

regulatory inspections, inspections, business insurance

IPO Preview: Horizon Pharma

Seeking Alpha

Monday, July 25, 2011 - 10:18am

tags:

IPOs, Horizon Pharma

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition

Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How Patient Engagement Can Reduce Brand Launch Risks

Drug Channels

The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead

Drug Channels

SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025

Drug Channels

Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)

Drug Channels

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)

Drug Channels

The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)

Drug Channels

What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)

Drug Channels

Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)

Drug Channels

Navigating Market Access Challenges in Life Sciences Commercialization

Drug Channels